Citius Oncology, Inc. Common Stock (CTOR)
Citius Oncology, Inc. Common Stock (CTOR) has reported earnings 6 times since Dec 27, 2024. The stock moves an average of ±5.84% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +5.62% (Aug 12, 2025) and its largest decline was -16.78% (May 15, 2026).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
6
Avg Abs. Movement
±5.84%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | ☽ POST | $0.98 | $0.98 | $0.98 | 0 | -16.78% | open_in_new |
| Feb 13, 2026 | ☀ PRE | $1.19 | $1.22 | $1.21 | 8,715 | +1.69% | open_in_new |
| Dec 23, 2025 | ☽ POST | $1.25 | $1.28 | $1.27 | 3,852 | -9.84% | open_in_new |
| Aug 12, 2025 | ☽ POST | $1.74 | $1.74 | $1.69 | 3,355 | +5.62% | open_in_new |
| May 14, 2025 | ☽ POST | $0.91 | $0.91 | $0.91 | 1,983 | -1.1% | open_in_new |
| Dec 27, 2024 | ☽ POST | $0.98 | $1.04 | $1.01 | 1,240 | +0% | open_in_new |
Earnings Count
6
Total earnings in dataset
Avg Abs. Movement
±5.84%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| EFFECT | 20260605 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260604 | open_in_new SEC.gov |
| 424B3 | 20260601 | open_in_new SEC.gov |
| 8-K | 20260601 | open_in_new SEC.gov |
| DEF 14C | 20260529 | open_in_new SEC.gov |
| S-3 | 20260529 | open_in_new SEC.gov |
| 424B3 | 20260522 | open_in_new SEC.gov |
| PRE 14C | 20260519 | open_in_new SEC.gov |
| 10-Q | 20260515 | open_in_new SEC.gov |
| 8-K | 20260515 | open_in_new SEC.gov |
Frequently asked about CTOR earnings
How much does CTOR stock move after earnings? expand_more
Over 6 reports, CTOR has moved an average of ±5.84% the session after earnings, closing higher 50.0% of the time.
What was CTOR's biggest post-earnings move? expand_more
CTOR's largest post-earnings gain on record was +5.62% on Aug 12, 2025, and its largest decline was -16.78% on May 15, 2026.
Where can I find Citius Oncology, Inc. Common Stock's SEC filings? expand_more
All of Citius Oncology, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right